| Date Filed | Type | Description |
| 06/05/2023 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 14,616 shares
@ $17.0078, valued at
$248.6k
Sold 12,018 shares
@ $17.0175, valued at
$204.5k
Sold 14,540 shares
@ $17.005, valued at
$247.3k
|
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 7,324 shares
@ $16.1591, valued at
$118.3k
|
|
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 47,132 options to buy
@ $19, valued at
$895.5k
|
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 12,250 options to buy
@ $21.9, valued at
$268.3k
Granted 3,356 restricted stock units
@ $0 |
|
| 06/08/2020 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
Exercised 7,333 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2019 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 689,655 shares
@ $1.45, valued at
$1000k
|
|
| 07/15/2019 |
4
| Aisling Capital IV, LP (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Bought 2,500,000 shares
@ $0.6, valued at
$1.5M
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC |
| 07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2018 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $18.35, valued at
$146.8k
|
|
| 04/12/2018 |
3/A
| Aisling Capital IV, LP (10% Owner) has filed a Form 3/A on Zosano Pharma Corp |
| 04/09/2018 |
3
| Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Zosano Pharma Corp |
| 12/20/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 250,000 shares
@ $80.5, valued at
$20.1M
|
|
| 11/27/2017 |
4
| AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 500,000 shares
@ $75, valued at
$37.5M
|
|
| 08/16/2017 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Bought 108,601 shares
@ $23.02, valued at
$2.5M
|
|
| 08/14/2017 |
4
| SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $26.97, valued at
$431.5k
|
|
| 08/14/2017 |
3
| SCHIFF ANDREW N (Director) has filed a Form 3 on Aclaris Therapeutics, Inc. |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|